John JF Jr - Search Results

1

The Forum for South Carolina Physicians.

John JF Jr. John JF Jr. J S C Med Assoc. 2015 Jun;111(2):44. J S C Med Assoc. 2015. PMID: 27132329 No abstract available.

2

Antibiotic resistance: a clinical danger beyond 2013.

John JF Jr, Steed LL. John JF Jr, et al. J S C Med Assoc. 2013 Jun;109(2):54-8. J S C Med Assoc. 2013. PMID: 24902392 Review. No abstract available.

3

Guidelines for reporting novel mecA gene homologues.

Ito T, Hiramatsu K, Tomasz A, de Lencastre H, Perreten V, Holden MT, Coleman DC, Goering R, Giffard PM, Skov RL, Zhang K, Westh H, O'Brien F, Tenover FC, Oliveira DC, Boyle-Vavra S, Laurent F, Kearns AM, Kreiswirth B, Ko KS, Grundmann H, Sollid JE, John JF Jr, Daum R, Soderquist B, Buist G; International Working Group on the Classification of Staphylococcal Cassette Chromosome Elements (IWG-SCC). Ito T, et al. Among authors: john jf jr. Antimicrob Agents Chemother. 2012 Oct;56(10):4997-9. doi: 10.1128/AAC.01199-12. Epub 2012 Aug 6. Antimicrob Agents Chemother. 2012. PMID: 22869575 Free PMC article. No abstract available.

4

All hazards planning and response in the Veterans Administration.

John JF Jr, Baker JM, Fraggos M, Adams C, Hutchison F. John JF Jr, et al. J S C Med Assoc. 2011 Jun;107(3):99-100. J S C Med Assoc. 2011. PMID: 22057713 No abstract available.

5

Clones and drones: do variants of Panton-Valentine leukocidin extend the reach of community-associated methicillin-resistant Staphylococcus aureus?

John JF Jr, Lindsay JA. John JF Jr, et al. J Infect Dis. 2008 Jan 15;197(2):175-8. doi: 10.1086/524693. J Infect Dis. 2008. PMID: 18177251 No abstract available.

6

Drug evaluation: tefibazumab--a monoclonal antibody against staphylococcal infection.

John JF Jr. John JF Jr. Curr Opin Mol Ther. 2006 Oct;8(5):455-60. Curr Opin Mol Ther. 2006. PMID: 17078388 Review.

7

Tolevamer, a novel nonantibiotic polymer, compared with vancomycin in the treatment of mild to moderately severe Clostridium difficile-associated diarrhea.

Louie TJ, Peppe J, Watt CK, Johnson D, Mohammed R, Dow G, Weiss K, Simon S, John JF Jr, Garber G, Chasan-Taber S, Davidson DM; Tolevamer Study Investigator Group. Louie TJ, et al. Among authors: john jf jr. Clin Infect Dis. 2006 Aug 15;43(4):411-20. doi: 10.1086/506349. Epub 2006 Jul 11. Clin Infect Dis. 2006. PMID: 16838228 Clinical Trial.

8

Necrotizing soft tissue infections: a guide to early diagnosis and initial therapy.

Majeski JA, John JF Jr. Majeski JA, et al. Among authors: john jf jr. South Med J. 2003 Sep;96(9):900-5. doi: 10.1097/01.SMJ.0000066658.35160.A1. South Med J. 2003. PMID: 14513988 Review.

9

HIV-1 reverse transcriptase mutations found in a drug-experienced patient confer reduced susceptibility to multiple nucleoside reverse transcriptase inhibitors.

Fitzgibbon JE, DiCola B, Arnold E, Das K, Sha BE, Pottage JC Jr, Nahass R, Gaur S, John JF Jr. Fitzgibbon JE, et al. Among authors: john jf jr. Antivir Ther. 2001 Dec;6(4):231-8. Antivir Ther. 2001. PMID: 11878404

10

A sequence variant of Staphylococcus hominis with a high prevalence of oxacillin and fluoroquinolone resistance.

Fitzgibbon JE, Nahvi MD, Dubin DT, John JF Jr. Fitzgibbon JE, et al. Among authors: john jf jr. Res Microbiol. 2001 Nov;152(9):805-10. doi: 10.1016/s0923-2508(01)01264-5. Res Microbiol. 2001. PMID: 11763241 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

72 results

Search Page

Filters